These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2082126)

  • 1. Pharmacokinetic analysis of blood distribution of intravenously administered 153Gd-labeled Gd(DTPA)2- and 99mTc(DTPA) in rats.
    Wedeking P; Eaton S; Covell DG; Nair S; Tweedle MF; Eckelman WC
    Magn Reson Imaging; 1990; 8(5):567-75. PubMed ID: 2082126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approximation of arterial input curve data in MRI estimation of cerebral blood-tumor-barrier leakage: comparison between Gd-DTPA and 99mTc-DTPA input curves.
    Andersen C; Taagehøj JF; Mühler A; Rehling M
    Magn Reson Imaging; 1996; 14(3):235-41. PubMed ID: 8725189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate, and gadodiamide in mice and rats.
    Tweedle MF; Wedeking P; Kumar K
    Invest Radiol; 1995 Jun; 30(6):372-80. PubMed ID: 7490190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the biodistribution of gadolinium-153 DTPA and technetium-99m DTPA in rats.
    Prato FS; Wisenberg G; Marshall TP; Uksik P; Zabel P
    J Nucl Med; 1988 Oct; 29(10):1683-7. PubMed ID: 3049959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic kinetics and magnetic resonance imaging of gadolinium ethoxybenzyl diethylenetriaminepentacetic acid (Gd-EOB-DTPA) in dogs.
    Benness G; Khangure M; Morris I; Warwick A; Burrows P
    Australas Radiol; 1993 Aug; 37(3):252-5. PubMed ID: 8373327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue relaxation enhancement after intravenous administration of (ITCB-DTPA)-gadolinum conjugated albumin, an intravascular magnetic resonance imaging contrast agent.
    Niemi P; Koskinen S; Reisto T
    Invest Radiol; 1991 Jul; 26(7):674-80. PubMed ID: 1885276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mannan-coated liposome delivery of gadolinium-diethylenetriaminepentaacetic acid, a contrast agent for use in magnetic resonance imaging.
    Kunimasa J; Inui K; Hori R; Kawamura Y; Endo K
    Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2565-7. PubMed ID: 1446380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodistribution and clearance of liposomal gadolinium-DTPA.
    Unger E; Cardenas D; Zerella A; Fajardo LL; Tilcock C
    Invest Radiol; 1990 Jun; 25(6):638-44. PubMed ID: 2354925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of dechelation of gadopentetate dimeglumine in rats.
    Kasokat T; Urich K
    Arzneimittelforschung; 1992 Jun; 42(6):869-76. PubMed ID: 1418049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance renography: optimisation of pulse sequence parameters and Gd-DTPA dose, and comparison with radionuclide renography.
    Taylor J; Summers PE; Keevil SF; Saks AM; Diskin J; Hilton PJ; Ayers AB
    Magn Reson Imaging; 1997; 15(6):637-49. PubMed ID: 9285803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: imaging characteristics in normal rat tissues.
    Wang SC; Wikström MG; White DL; Klaveness J; Holtz E; Rongved P; Moseley ME; Brasch RC
    Radiology; 1990 May; 175(2):483-8. PubMed ID: 1691513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clearance of liposomal gadolinium: in vivo decomplexation.
    Unger EC; Fritz TA; Tilcock C; New TE
    J Magn Reson Imaging; 1991; 1(6):689-93. PubMed ID: 1823174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudolayering of Gd-DTPA in the urinary bladder.
    Elster AD; Sobol WT; Hinson WH
    Radiology; 1990 Feb; 174(2):379-81. PubMed ID: 2296649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Issue of Gadolinium Retained in Tissues: Insights on the Role of Metal Complex Stability by Comparing Metal Uptake in Murine Tissues Upon the Concomitant Administration of Lanthanum- and Gadolinium-Diethylentriamminopentaacetate.
    Di Gregorio E; Ferrauto G; Furlan C; Lanzardo S; Nuzzi R; Gianolio E; Aime S
    Invest Radiol; 2018 Mar; 53(3):167-172. PubMed ID: 28990973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrated clearance of gadolinium-DTPA as a measurement of glomerular filtration rate.
    Choyke PL; Austin HA; Frank JA; Girton ME; Diggs RL; Dwyer AJ; Miller L; Nussenblatt R; McFarland H; Simon T
    Kidney Int; 1992 Jun; 41(6):1595-8. PubMed ID: 1501414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revisiting the Pharmacokinetic Profiles of Gadolinium-Based Contrast Agents: Differences in Long-Term Biodistribution and Excretion.
    Lancelot E
    Invest Radiol; 2016 Nov; 51(11):691-700. PubMed ID: 27175546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the biodistribution of 153Gd-labeled Gd(DTPA)2-, Gd(DOTA)-, and Gd(acetate)n in mice.
    Wedeking P; Tweedle M
    Int J Rad Appl Instrum B; 1988; 15(4):395-402. PubMed ID: 3255735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aerosolized gadolinium-DTPA enhances the magnetic resonance signal of extravascular lung water.
    Montgomery AB; Paajanen H; Brasch RC; Murray JF
    Invest Radiol; 1987 May; 22(5):377-81. PubMed ID: 3597005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo imaging of extraction fraction of low molecular weight MR contrast agents and perfusion rate in rodent tumors.
    Kovar DA; Lewis MZ; River JN; Lipton MJ; Karczmar GS
    Magn Reson Med; 1997 Aug; 38(2):259-68. PubMed ID: 9256106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodistribution and excretion of 153Gd-labeled gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid following repeated intravenous administration to rats.
    Mühler A; Weinmann HJ
    Acad Radiol; 1995 Apr; 2(4):313-8. PubMed ID: 9419568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.